The activation of Vδ1+ cells by TCR engagement combined with cytokine stimulation (i.e., IL-2 or IL-15) upregulates NKRs, correlating with CD56 expression and potent anti-tumour cytotoxicity [76,91]. Here, IL2 is linked to neoplasm.